APO Research
Talk to an analyst

APO RESEARCH · REPORT

20s Proteasome

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global 20s Proteasome Industry Growth and Trends Forecast to 2032

19 December 202575 pages

Choose your research edition.

Industry Research20s Proteasome Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal 20s Proteasome Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal 20s Proteasome Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 20s Proteasome Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal 20s Proteasome Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global 20s Proteasome market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for 20s Proteasome is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for 20s Proteasome is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 20s Proteasome is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 20s Proteasome include Amgen Inc and Celgene Corp among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global 20s Proteasome market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The 20s Proteasome market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 20s Proteasome market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 20s Proteasome.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global 20s Proteasome market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

20s Proteasome Market by Company

Amgen Inc

Celgene Corp

20s Proteasome Segment by Type

Marizomib

Carfilzomib

Oprozomib

VPEA-002

Others

20s Proteasome Segment by Application

Neuroendocrine Cancer

Ovarian Cancer

Lymphoma

Colon Cancer

Malignant Glioma

Others

20s Proteasome Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 20s Proteasome market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 20s Proteasome and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 20s Proteasome.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 20s Proteasome manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of 20s Proteasome in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Marizomib Table 2. Major Company of Carfilzomib Table 3. Major Company of Oprozomib Table 4. Major Company of VPEA-002 Table 5. Major Company of Others Table 6. Global 20s Proteasome Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global 20s Proteasome Sales by Type (2021-2026) & (K Units) Table 8. Global 20s Proteasome Sales Market Share in Volume by Type (2021-2026) Table 9. Global 20s Proteasome Sales by Type (2021-2026) & (US$ Million) Table 10. Global 20s Proteasome Sales Market Share in Value by Type (2021-2026) Table 11. Global 20s Proteasome Price by Type (2021-2026) & (US$/Unit) Table 12. Global 20s Proteasome Sales by Type (2027-2032) & (K Units) Table 13. Global 20s Proteasome Sales Market Share in Volume by Type (2027-2032) Table 14. Global 20s Proteasome Sales by Type (2027-2032) & (US$ Million) Table 15. Global 20s Proteasome Sales Market Share in Value by Type (2027-2032) Table 16. Global 20s Proteasome Price by Type (2027-2032) & (US$/Unit) Table 17. North America 20s Proteasome Sales by Type (2021-2026) & (K Units) Table 18. North America 20s Proteasome Sales by Type (2021-2026) & (US$ Million) Table 19. Europe 20s Proteasome Sales by Type (2021-2026) & (K Units) Table 20. Europe 20s Proteasome Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific 20s Proteasome Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific 20s Proteasome Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America 20s Proteasome Sales by Type (2021-2026) & (K Units) Table 24. Latin America 20s Proteasome Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa 20s Proteasome Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa 20s Proteasome Sales by Type (2021-2026) & (US$ Million) Table 27. 20s Proteasome Industry Trends Table 28. 20s Proteasome Industry Drivers Table 29. 20s Proteasome Industry Opportunities and Challenges Table 30. 20s Proteasome Industry Restraints Table 31. Global 20s Proteasome Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global 20s Proteasome Revenue Market Share by Company (2021-2026) Table 33. Global 20s Proteasome Sales by Company (2021-2026) & (K Units) Table 34. Global 20s Proteasome Sales Share by Company (2021-2026) Table 35. Global 20s Proteasome Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global 20s Proteasome Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global 20s Proteasome Major Company Production Sites and Headquarters Table 38. Global 20s Proteasome Company, Product Type & Application Table 39. Global 20s Proteasome Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global 20s Proteasome by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global 20s Proteasome Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global 20s Proteasome Sales by Region (2021-2026) & (K Units) Table 44. Global 20s Proteasome Sales Market Share in Volume by Region (2021-2026) Table 45. Global 20s Proteasome Sales by Region (2021-2026) & (US$ Million) Table 46. Global 20s Proteasome Sales Market Share in Value by Region (2021-2026) Table 47. Global 20s Proteasome Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global 20s Proteasome Sales by Region (2027-2032) & (K Units) Table 49. Global 20s Proteasome Sales Market Share in Volume by Region (2027-2032) Table 50. Global 20s Proteasome Sales by Region (2027-2032) & (US$ Million) Table 51. Global 20s Proteasome Sales Market Share in Value by Region (2027-2032) Table 52. Global 20s Proteasome Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global 20s Proteasome Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global 20s Proteasome Sales by Application (2021-2026) & (K Units) Table 55. Global 20s Proteasome Sales Market Share in Volume by Application (2021-2026) Table 56. Global 20s Proteasome Sales by Application (2021-2026) & (US$ Million) Table 57. Global 20s Proteasome Sales Market Share in Value by Application (2021-2026) Table 58. Global 20s Proteasome Price by Application (2021-2026) & (US$/Unit) Table 59. Global 20s Proteasome Sales by Application (2027-2032) & (K Units) Table 60. Global 20s Proteasome Sales Market Share in Volume by Application (2027-2032) Table 61. Global 20s Proteasome Sales by Application (2027-2032) & (US$ Million) Table 62. Global 20s Proteasome Sales Market Share in Value by Application (2027-2032) Table 63. Global 20s Proteasome Price by Application (2027-2032) & (US$/Unit) Table 64. North America 20s Proteasome Sales by Application (2021-2026) & (K Units) Table 65. North America 20s Proteasome Sales by Application (2021-2026) & (US$ Million) Table 66. Europe 20s Proteasome Sales by Application (2021-2026) & (K Units) Table 67. Europe 20s Proteasome Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific 20s Proteasome Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific 20s Proteasome Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America 20s Proteasome Sales by Application (2021-2026) & (K Units) Table 71. Latin America 20s Proteasome Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa 20s Proteasome Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa 20s Proteasome Sales by Application (2021-2026) & (US$ Million) Table 74. Amgen Inc Company Information Table 75. Amgen Inc Business Overview Table 76. Amgen Inc 20s Proteasome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Amgen Inc 20s Proteasome Product Portfolio Table 78. Amgen Inc Recent Development Table 79. Celgene Corp Company Information Table 80. Celgene Corp Business Overview Table 81. Celgene Corp 20s Proteasome Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Celgene Corp 20s Proteasome Product Portfolio Table 83. Celgene Corp Recent Development Table 84. North America 20s Proteasome Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 85. North America 20s Proteasome Sales by Country (2021-2026) & (K Units) Table 86. North America 20s Proteasome Sales Market Share by Country (2021-2026) Table 87. North America 20s Proteasome Sales Forecast by Country (2027-2032) & (K Units) Table 88. North America 20s Proteasome Sales Market Share Forecast by Country (2027-2032) Table 89. North America 20s Proteasome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 90. North America 20s Proteasome Market Size by Country (2021-2026) & (US$ Million) Table 91. North America 20s Proteasome Market Share by Country (2021-2026) Table 92. North America 20s Proteasome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 93. North America 20s Proteasome Market Share Forecast by Country (2027-2032) Table 94. Europe 20s Proteasome Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 95. Europe 20s Proteasome Sales by Country (2021-2026) & (K Units) Table 96. Europe 20s Proteasome Sales Market Share by Country (2021-2026) Table 97. Europe 20s Proteasome Sales Forecast by Country (2027-2032) & (K Units) Table 98. Europe 20s Proteasome Sales Market Share Forecast by Country (2027-2032) Table 99. Europe 20s Proteasome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. Europe 20s Proteasome Market Size by Country (2021-2026) & (US$ Million) Table 101. Europe 20s Proteasome Market Share by Country (2021-2026) Table 102. Europe 20s Proteasome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. Europe 20s Proteasome Market Share Forecast by Country (2027-2032) Table 104. Asia-Pacific 20s Proteasome Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 105. Asia-Pacific 20s Proteasome Sales by Country (2021-2026) & (K Units) Table 106. Asia-Pacific 20s Proteasome Sales Market Share by Country (2021-2026) Table 107. Asia-Pacific 20s Proteasome Sales Forecast by Country (2027-2032) & (K Units) Table 108. Asia-Pacific 20s Proteasome Sales Market Share Forecast by Country (2027-2032) Table 109. Asia-Pacific 20s Proteasome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Asia-Pacific 20s Proteasome Market Size by Country (2021-2026) & (US$ Million) Table 111. Asia-Pacific 20s Proteasome Market Share by Country (2021-2026) Table 112. Asia-Pacific 20s Proteasome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Asia-Pacific 20s Proteasome Market Share Forecast by Country (2027-2032) Table 114. Latin America 20s Proteasome Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 115. Latin America 20s Proteasome Sales by Country (2021-2026) & (K Units) Table 116. Latin America 20s Proteasome Sales Market Share by Country (2021-2026) Table 117. Latin America 20s Proteasome Sales Forecast by Country (2027-2032) & (K Units) Table 118. Latin America 20s Proteasome Sales Market Share Forecast by Country (2027-2032) Table 119. Latin America 20s Proteasome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Latin America 20s Proteasome Market Size by Country (2021-2026) & (US$ Million) Table 121. Latin America 20s Proteasome Market Share by Country (2021-2026) Table 122. Latin America 20s Proteasome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Latin America 20s Proteasome Market Share Forecast by Country (2027-2032) Table 124. Middle East and Africa 20s Proteasome Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. Middle East and Africa 20s Proteasome Sales by Country (2021-2026) & (K Units) Table 126. Middle East and Africa 20s Proteasome Sales Market Share by Country (2021-2026) Table 127. Middle East and Africa 20s Proteasome Sales Forecast by Country (2027-2032) & (K Units) Table 128. Middle East and Africa 20s Proteasome Sales Market Share Forecast by Country (2027-2032) Table 129. Middle East and Africa 20s Proteasome Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Middle East and Africa 20s Proteasome Market Size by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa 20s Proteasome Market Share by Country (2021-2026) Table 132. Middle East and Africa 20s Proteasome Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Middle East and Africa 20s Proteasome Market Share Forecast by Country (2027-2032) Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. 20s Proteasome Distributors List Table 137. 20s Proteasome Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. 20s Proteasome Image Figure 2. Global 20s Proteasome Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 20s Proteasome Market Size (2021-2032) & (US$ Million) Figure 4. Global 20s Proteasome Sales (2021-2032) & (K Units) Figure 5. Marizomib Image Figure 6. Global Marizomib Sales YoY Growth (2021-2032) & (K Units) Figure 7. Carfilzomib Image Figure 8. Global Carfilzomib Sales YoY Growth (2021-2032) & (K Units) Figure 9. Oprozomib Image Figure 10. Global Oprozomib Sales YoY Growth (2021-2032) & (K Units) Figure 11. VPEA-002 Image Figure 12. Global VPEA-002 Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global 20s Proteasome Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global 20s Proteasome Market Share by Type 2025 VS 2032 Figure 17. North America 20s Proteasome Sales Market Share in Volume by Type in 2025 Figure 18. North America 20s Proteasome Sales Market Share in Value by Type in 2025 Figure 19. Europe 20s Proteasome Sales Market Share in Volume by Type in 2025 Figure 20. Europe 20s Proteasome Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific 20s Proteasome Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific 20s Proteasome Sales Market Share in Value by Type in 2025 Figure 23. Latin America 20s Proteasome Sales Market Share in Volume by Type in 2025 Figure 24. Latin America 20s Proteasome Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa 20s Proteasome Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa 20s Proteasome Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 20s Proteasome Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Neuroendocrine Cancer Image Figure 30. Global Neuroendocrine Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Ovarian Cancer Image Figure 32. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Lymphoma Image Figure 34. Global Lymphoma Sales YoY Growth (2021-2032) & (K Units) Figure 35. Colon Cancer Image Figure 36. Global Colon Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 37. Malignant Glioma Image Figure 38. Global Malignant Glioma Sales YoY Growth (2021-2032) & (K Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 41. Global 20s Proteasome Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global 20s Proteasome Market Share by Application 2025 VS 2032 Figure 43. North America 20s Proteasome Sales Market Share in Volume by Application in 2025 Figure 44. North America 20s Proteasome Sales Market Share in Value by Application in 2025 Figure 45. Europe 20s Proteasome Sales Market Share in Volume by Application in 2025 Figure 46. Europe 20s Proteasome Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific 20s Proteasome Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific 20s Proteasome Sales Market Share in Value by Application in 2025 Figure 49. Latin America 20s Proteasome Sales Market Share in Volume by Application in 2025 Figure 50. Latin America 20s Proteasome Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa 20s Proteasome Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa 20s Proteasome Sales Market Share in Value by Application in 2025 Figure 53. North America 20s Proteasome Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. North America 20s Proteasome Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America 20s Proteasome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America 20s Proteasome Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe 20s Proteasome Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Europe 20s Proteasome Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe 20s Proteasome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe 20s Proteasome Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific 20s Proteasome Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Asia-Pacific 20s Proteasome Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific 20s Proteasome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific 20s Proteasome Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America 20s Proteasome Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Latin America 20s Proteasome Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America 20s Proteasome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America 20s Proteasome Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa 20s Proteasome Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Middle East and Africa 20s Proteasome Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa 20s Proteasome Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa 20s Proteasome Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. 20s Proteasome Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. 20s Proteasome Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Marizomib
  • Carfilzomib
  • Oprozomib
  • VPEA-002
  • Others
Applications
  • Neuroendocrine Cancer
  • Ovarian Cancer
  • Lymphoma
  • Colon Cancer
  • Malignant Glioma
  • Others
Companies covered
  • Amgen Inc
  • Celgene Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 20s Proteasome Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global 20s Proteasome Sales Estimates and Forecasts (2021-2032)
  5. 1.3 20s Proteasome Market by Type
  6. 1.3.1 Marizomib
  7. 1.3.2 Carfilzomib
  8. 1.3.3 Oprozomib
  9. 1.3.4 VPEA-002
  10. 1.3.5 Others
  11. 1.4 Global 20s Proteasome Market Size by Type
  12. 1.4.1 Global 20s Proteasome Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global 20s Proteasome Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global 20s Proteasome Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America 20s Proteasome Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe 20s Proteasome Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific 20s Proteasome Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America 20s Proteasome Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa 20s Proteasome Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 20s Proteasome Industry Trends
  2. 2.2 20s Proteasome Industry Drivers
  3. 2.3 20s Proteasome Industry Opportunities and Challenges
  4. 2.4 20s Proteasome Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by 20s Proteasome Revenue (2021-2026)
  2. 3.2 Global Top Players by 20s Proteasome Sales (2021-2026)
  3. 3.3 Global Top Players by 20s Proteasome Price (2021-2026)
  4. 3.4 Global 20s Proteasome Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 20s Proteasome Major Company Production Sites & Headquarters
  6. 3.6 Global 20s Proteasome Company, Product Type & Application
  7. 3.7 Global 20s Proteasome Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 20s Proteasome Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 20s Proteasome Players Market Share by Revenue in 2025
  11. 3.8.3 2025 20s Proteasome Tier 1, Tier 2, and Tier 3
4 20s Proteasome Regional Status and Outlook
  1. 4.1 Global 20s Proteasome Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global 20s Proteasome Historic Market Size by Region
  3. 4.2.1 Global 20s Proteasome Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global 20s Proteasome Sales in Value by Region (2021-2026)
  5. 4.2.3 Global 20s Proteasome Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global 20s Proteasome Forecasted Market Size by Region
  7. 4.3.1 Global 20s Proteasome Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global 20s Proteasome Sales in Value by Region (2027-2032)
  9. 4.3.3 Global 20s Proteasome Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 20s Proteasome by Application
  1. 5.1 20s Proteasome Market by Application
  2. 5.1.1 Neuroendocrine Cancer
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Lymphoma
  5. 5.1.4 Colon Cancer
  6. 5.1.5 Malignant Glioma
  7. 5.1.6 Others
  8. 5.2 Global 20s Proteasome Market Size by Application
  9. 5.2.1 Global 20s Proteasome Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global 20s Proteasome Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global 20s Proteasome Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America 20s Proteasome Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe 20s Proteasome Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific 20s Proteasome Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America 20s Proteasome Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa 20s Proteasome Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amgen Inc
  2. 6.1.1 Amgen Inc Company Information
  3. 6.1.2 Amgen Inc Business Overview
  4. 6.1.3 Amgen Inc 20s Proteasome Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amgen Inc 20s Proteasome Product Portfolio
  6. 6.1.5 Amgen Inc Recent Developments
  7. 6.2 Celgene Corp
  8. 6.2.1 Celgene Corp Company Information
  9. 6.2.2 Celgene Corp Business Overview
  10. 6.2.3 Celgene Corp 20s Proteasome Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Celgene Corp 20s Proteasome Product Portfolio
  12. 6.2.5 Celgene Corp Recent Developments
7 North America by Country
  1. 7.1 North America 20s Proteasome Sales by Country
  2. 7.1.1 North America 20s Proteasome Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America 20s Proteasome Sales by Country (2021-2026)
  4. 7.1.3 North America 20s Proteasome Sales Forecast by Country (2027-2032)
  5. 7.2 North America 20s Proteasome Market Size by Country
  6. 7.2.1 North America 20s Proteasome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America 20s Proteasome Market Size by Country (2021-2026)
  8. 7.2.3 North America 20s Proteasome Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe 20s Proteasome Sales by Country
  2. 8.1.1 Europe 20s Proteasome Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe 20s Proteasome Sales by Country (2021-2026)
  4. 8.1.3 Europe 20s Proteasome Sales Forecast by Country (2027-2032)
  5. 8.2 Europe 20s Proteasome Market Size by Country
  6. 8.2.1 Europe 20s Proteasome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe 20s Proteasome Market Size by Country (2021-2026)
  8. 8.2.3 Europe 20s Proteasome Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific 20s Proteasome Sales by Country
  2. 9.1.1 Asia-Pacific 20s Proteasome Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific 20s Proteasome Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific 20s Proteasome Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific 20s Proteasome Market Size by Country
  6. 9.2.1 Asia-Pacific 20s Proteasome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific 20s Proteasome Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific 20s Proteasome Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America 20s Proteasome Sales by Country
  2. 10.1.1 South America 20s Proteasome Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America 20s Proteasome Sales by Country (2021-2026)
  4. 10.1.3 South America 20s Proteasome Sales Forecast by Country (2027-2032)
  5. 10.2 South America 20s Proteasome Market Size by Country
  6. 10.2.1 South America 20s Proteasome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America 20s Proteasome Market Size by Country (2021-2026)
  8. 10.2.3 South America 20s Proteasome Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa 20s Proteasome Sales by Country
  2. 11.1.1 Middle East and Africa 20s Proteasome Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa 20s Proteasome Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa 20s Proteasome Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa 20s Proteasome Market Size by Country
  6. 11.2.1 Middle East and Africa 20s Proteasome Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa 20s Proteasome Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa 20s Proteasome Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 20s Proteasome Value Chain Analysis
  2. 12.1.1 20s Proteasome Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 20s Proteasome Production Mode & Process
  7. 12.2 20s Proteasome Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 20s Proteasome Distributors
  10. 12.2.3 20s Proteasome Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst